Through the 90-day period concluding February 19, 2026, ArriVent BioPharma's top three insider stakeholders include TenPercentOwner Investment Management, Ltd. Hillhouse (3.93Mn shares), Director James Healy (1.70Mn shares), Director Carl L Gordon (1.51Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Investment Management, Ltd. Hillhouse | 3,929,117 | 03 Feb, 2026 | |
| James Healy | 1,696,752 | 31 Jan, 2024 | |
| Advisors Llc Orbimed | 1,513,664 | 31 Jan, 2024 | |
| Carl L Gordon | 1,513,664 | 31 Jan, 2024 | |
| Robin Lachapelle | Chief Operating Officer | 135,736 | 15 Jul, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Dec, 2025 | Investment Management, Ltd. Hillhouse | Common Stock | D | 555,555 | $23.37 | 3,929,117 | I | S |
| 11 Jul, 2025 | Robin Lachapelle | - | - | 126,633 | D | |||
| 11 Jul, 2025 | Robin Lachapelle | - | - | 135,736 | D | |||
| 11 Jul, 2025 | Robin Lachapelle | Common Stock | A | 2,050 | $2.28 | 126,633 | D | M |
| 11 Jul, 2025 | Robin Lachapelle | - | - | 129,233 | D | |||
| 11 Jul, 2025 | Robin Lachapelle | Common Stock | A | 6,503 | $2.28 | 135,736 | D | M |
| 11 Jul, 2025 | Robin Lachapelle | Common Stock | A | 2,600 | $2.28 | 129,233 | D | M |
| 19 Sep, 2024 | Robin Lachapelle | Common Stock | A | 2,471 | $2.28 | 112,219 | D | M |
| 19 Sep, 2024 | Robin Lachapelle | Common Stock | A | 7,164 | $2.28 | 109,748 | D | M |
| 19 Sep, 2024 | Robin Lachapelle | Common Stock | A | 2,867 | $2.28 | 102,584 | D | M |
| 19 Sep, 2024 | Robin Lachapelle | Common Stock | A | 12,364 | $3.65 | 124,583 | D | M |
| 19 Sep, 2024 | Robin Lachapelle | Common Stock | A | 2,700 | $6.24 | 99,717 | D | M |
| 30 Jan, 2024 | Advisors Llc Orbimed | - | - | 1,291,442 | I | |||
| 30 Jan, 2024 | Advisors Llc Orbimed | Common Stock | A | 469,615 | - | 1,291,442 | I | C |
| 30 Jan, 2024 | Advisors Llc Orbimed | - | - | 1,513,664 | I | |||
| 30 Jan, 2024 | Advisors Llc Orbimed | Common Stock | A | 469,615 | - | 1,291,442 | I | C |
| 30 Jan, 2024 | Advisors Llc Orbimed | Common Stock | A | 821,827 | - | 821,827 | I | C |
| 30 Jan, 2024 | Advisors Llc Orbimed | Common Stock | A | 222,222 | $18.00 | 1,513,664 | I | P |
| 30 Jan, 2024 | Advisors Llc Orbimed | - | - | 821,827 | I | |||
| 30 Jan, 2024 | Advisors Llc Orbimed | - | - | 1,291,442 | I |